Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taimur Sher

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Cancer|January 24, 2018
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparitiesSikander Ailawadhi, Ryan D Frank, Mayank Sharma, et al.
Blood Advances|May 19, 2020
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responsesAlak Manna, Timothy Kellett, Sonikpreet Aulakh, et al.
Anti-Cancer Drugs|August 16, 2019
Monoclonal antibody utilization characteristics in patients with multiple myelomaSikander Ailawadhi, Taimur Sher, Abdel-Ghani Azzouqa, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic MinoritiesSikander Ailawadhi, Abdel-Ghani Azzouqa, David Hodge, et al.
Leukemia & Lymphoma|January 9, 2010
Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogeneticsTaimur Sher, Kena C Miller, David Lawrence, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic LeukemiaAlak Manna, Sonikpreet Aulakh, Prachi Jani, et al.
JCO Oncology Practice|February 13, 2020
Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient CareVivek Kumar, Muhamad Alhaj-Moustafa, Leyla Bojanini, et al.
Haematologica|April 21, 2019
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman diseaseGaurav Goyal, Aishwarya Ravindran, Jason R Young, et al.
Blood Cancer Journal|October 2, 2019
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemiaVivek Kumar, Sikander Ailawadhi, Leyla Bojanini, et al.
Advances in Radiation Oncology|August 19, 2021
Comparable Efficacy of Reduced Dose Radiation Therapy for the Treatment of Early Stage Gastric Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueOmran Saifi, Scott C Lester, William Rule, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Cancer|January 24, 2018
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparitiesSikander Ailawadhi, Ryan D Frank, Mayank Sharma, et al.
Blood Advances|May 19, 2020
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responsesAlak Manna, Timothy Kellett, Sonikpreet Aulakh, et al.
Anti-Cancer Drugs|August 16, 2019
Monoclonal antibody utilization characteristics in patients with multiple myelomaSikander Ailawadhi, Taimur Sher, Abdel-Ghani Azzouqa, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic MinoritiesSikander Ailawadhi, Abdel-Ghani Azzouqa, David Hodge, et al.
Leukemia & Lymphoma|January 9, 2010
Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogeneticsTaimur Sher, Kena C Miller, David Lawrence, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2019
Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic LeukemiaAlak Manna, Sonikpreet Aulakh, Prachi Jani, et al.
JCO Oncology Practice|February 13, 2020
Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient CareVivek Kumar, Muhamad Alhaj-Moustafa, Leyla Bojanini, et al.
Haematologica|April 21, 2019
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman diseaseGaurav Goyal, Aishwarya Ravindran, Jason R Young, et al.
Blood Cancer Journal|October 2, 2019
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemiaVivek Kumar, Sikander Ailawadhi, Leyla Bojanini, et al.
Advances in Radiation Oncology|August 19, 2021
Comparable Efficacy of Reduced Dose Radiation Therapy for the Treatment of Early Stage Gastric Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueOmran Saifi, Scott C Lester, William Rule, et al.
Pageof 12